October 31, 2013 at 13:14 PM EDT
Aria Suspends Iclusig Sales
Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) temporarily suspended sales of its leukemia treatment Iclusig at the request of the Food and Drug Administration. The stock price plummeted $1.55 to $2.42.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here